# Value Chain Companies Data

Source: report/20260121_new input/Value_Chain_Companies.xlsx

## Sheet: Mobility 

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| Nutramax | DasuquinÂ® | Glucosamine, Chondroitin, ASU (Avocado/Soy Unsaponifiables), Green Tea | Dogs, Cats | Nutramax (Vertical) | The US #1: The undisputed leader. Proprietary ASU outperforms standard Glucosamine. | ðŸ”— Nutramax Site |
| Bioiberica | CondrovetÂ® Force HA | Chondroitin Sulfate, Glucosamine, Hyaluronic Acid, Type II Collagen | Dogs, Cats | Bioiberica (Vertical) | The EU #1: Vertical integration of Heparin/Chondroitin makes them the lowest-cost high-quality producer. | ðŸ”— Bioiberica Page |
| Vetoquinol | FlexadinÂ® Advanced | UC-IIÂ® (Undenatured Type II Collagen), Omega-3, Vitamin E | Dogs, Cats | Lonza (Licensor) | Drug Replacement: Induces oral tolerance to stop inflammation (alternative to NSAIDs). | ðŸ”— Vetoquinol USA |
| Lintbells | YuMOVE Joint Care | ActivEaseÂ® Green Lipped Mussel, Glucosamine, Hyaluronic Acid | Dogs | Lintbells (Vertical) | Supply Chain Control: Owns the mussel bays in NZ to guarantee 4x higher potency. | ðŸ”— Lintbells Science |
| VetriScience | GlycoFlexÂ® 3 | Perna canaliculus (GlycOmegaâ„¢), Glucosamine, MSM, DMG | Dogs | Aroma NZ (Supplier) | Clinical Legacy: The original "Gold Standard" formula used by US vets for 40+ years. | ðŸ”— Drugs.com |


## Sheet: Gut Health 

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| NestlÃ© Purina | FortiFloraÂ® | Enterococcus faecium SF68, Vitamin C, Vitamin E | Dogs, Cats | NestlÃ© Research | Market Dominance: The #1 prescribed probiotic globally. Proprietary microencapsulation. | ðŸ”— Purina SF68 |
| Protexin (ADM) | Pro-Kolin | Probiotics (E. faecium), PreplexÂ® Prebiotic, Kaolin, Pectin | Dogs, Cats | ADM (Vertical) | The EU Standard: The reference paste for acute diarrhea (Kaolin + Probiotic synergy). | ðŸ”— Protexin Page |
| Zesty Paws | Probiotic Bites | Bacillus subtilis DE111Â®, Pumpkin, Papaya | Dogs | ADM (Licensor) | Spore Tech: Uses hardy spore-forming bacteria (DE111) that survive manufacturing heat. | ðŸ”— ADM Sell Sheet |
| AnimalBiome | Gut Restore | Fecal Microbiota Transplant (FMT) material (Oral Capsules) | Dogs, Cats | AnimalBiome | Restoration: Reseeds the entire ecosystem, not just adding one strain. | ðŸ”— Patent App |


## Sheet: Immunity 

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| Diamond V (Cargill) | Original XPCâ„¢ | Postbiotics (Saccharomyces cerevisiae fermentation metabolites) | Livestock, Dogs | Cargill (Vertical) | The Original Postbiotic: The global reference for "Immune Training." Optimizes gut structure without live bacteria. | ðŸ”— Diamond V Science |
| Swedencare | ProDen PlaqueOffÂ® | Ascophyllum nodosum (D1070â„¢ Kelp) | Dogs, Cats | Swedencare (Vertical) | Systemic Action: The algae is absorbed into the blood and secreted into saliva to prevent plaque (Systemic, not local). | ðŸ”— Swedencare Tech |
| Olmix | AlgimunÂ® | Macroalgae Extracts (MSPÂ® - Sulfated Polysaccharides) | Livestock, Aqua | Olmix (Vertical) | Marine Immunity: Specific algae sugars (MSP) that unlock the gut's immune receptors (TLRs) better than yeast. | ðŸ”— Olmix MSP Page |
| Leiber GmbH | BiolexÂ® MB40 | Beta-Glucans & MOS (Brewers' Yeast Cell Walls) | Livestock, Pets | Leiber (Vertical) | Surface Structure: Unique high-surface-area yeast hulls that bind pathogens (E. coli/Salmonella) like a magnet. | ðŸ”— Leiber Brewers Yeast |
| Phytobiotics | SangrovitÂ® | Isoquinoline Alkaloids (Macleaya cordata) | Livestock | Phytobiotics (Vertical) | Gut Integrity: Plant-based alkaloids that reduce intestinal inflammation, saving energy for growth. | ðŸ”— Sangrovit Page |


## Sheet: Cognitive 

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| NestlÃ© Purina | Bright MindÂ® | Medium Chain Triglycerides (MCTs) (C8/C10 Blend) | Senior Dogs | NestlÃ© (Patent) | Metabolic Fuel: Uses MCTs as an alternative energy source for the aging brain (Glucose bypass). | ðŸ”— US Patent 8962050 |
| Ceva | SenilifeÂ® | Phosphatidylserine, Ginkgo Biloba, Vitamin B6, Resveratrol | Senior Dogs | Ceva (Vertical) | Neuro-Protection: The reference veterinary formula for reversing "Sundowner Syndrome." | ðŸ”— Ceva Senilife |
| Virbac | NovifitÂ® | SAMe (S-Adenosylmethionine) | Senior Dogs | Virbac | Dual Action: Supports both Liver function (Glutathione) and Brain function (Cognition). | ðŸ”— Virbac Novifit |


## Sheet: Calming 

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| NestlÃ© Purina | Calming Care | Bifidobacterium longum BL999 (Probiotic strain) | Dogs | NestlÃ© Research | Gut-Brain Axis: Proprietary strain proven to blunt cortisol (stress hormone) via the vagus nerve. | ðŸ”— ProPlanVetDirect |
| Ceva | AdaptilÂ® Chew | Thiamine, L-Tryptophan, Green Tea Extract, Colostrum | Dogs | Ceva (Vertical) | Brand Power: Leverages the world's #1 pheromone brand (Adaptil) into an edible format. | ðŸ”— Adaptil.com |
| Vetoquinol | ZylkÃ¨neÂ® | Alpha-Casozepine (LactiumÂ®), Hydrolyzed Milk Protein | Dogs, Cats | Ingredia (Licensor) | Speed: Acts on GABA receptors instantly (like Valium) without sedation. | ðŸ”— Vetoquinol Tech |
| Virbac | AnxitaneÂ® | L-Theanine (SuntheanineÂ®) | Dogs, Cats | Taiyo (Licensor) | Focus: The only pure L-Theanine chew backed by global veterinary safety data. | ðŸ”— Virbac Profile |
| ElleVet | Calm & Comfort | CBD + CBDA (Proprietary Hemp Blend) | Dogs | ElleVet (Vertical) | Regulatory Lead: The only Cannabis strain with significant university clinical data (Cornell). | ðŸ”— Cornell Study |


## Sheet: Performance

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| Zinpro | AvailaÂ® | Performance Minerals (Zinc, Manganese, Copper Amino Acid Complexes) | Livestock | Zinpro (Vertical) | Bioavailability: The only minerals that use amino-acid transporters to bypass digestion blocks. | ðŸ”— Zinpro Science |
| Adisseo | RovabioÂ® | Multi-Enzyme Complex (Xylanase, Glucanase) | Poultry, Swine | Adisseo (Vertical) | The Nutrient Unlocker: Dismantles plant fibers to "create" energy from cheap feed ingredients. | ðŸ”— Adisseo Page |
| Evonik | MetAMINOÂ® | DL-Methionine (99% pure) | Poultry, Swine | Evonik (Vertical) | The Bottleneck: The world's purest source of the #1 limiting amino acid for muscle growth. | ðŸ”— Evonik Page |
| DSM | RonozymeÂ® | Phytase, Protease, Amylase | Poultry, Swine | DSM-Firmenich | Phosphate Replacement: Liberates bound phosphorus, eliminating the need for rock phosphate. | ðŸ”— DSM Page |


## Sheet: Ectoparasites

| Company (Commercial) | Product | Active Ingredients | Target Species | Mechanism of Action | The Strategic Claim |
| --- | --- | --- | --- | --- | --- |
| Anpario | Mitex | Diatomaceous Earth (Physical Action) | Poultry, Swine | Mechanical Killer: Microscopic shards pierce the insect's waxy exoskeleton, causing dehydration and death. No resistance possible. | Resistance-Proof: Unlike chemicals, mites cannot mutate to survive physical destruction. 98.5% efficacy vs. chemical standard. |
| Bioiberica | AtopivetÂ® | Nucleotides + Hyaluronic Acid | Dogs, Cats | Skin Barrier Reinforcement: Strengthens the physical skin barrier from the inside out, making it harder for allergens/parasites to penetrate. | Systemic Shield: The only oral product proven to thicken the dermal barrier, reducing "entry points" for flea allergy dermatitis. |
| Phytobiotics | MiaromÂ® | Essential Oils (Thyme, Anise, Peppermint) | Poultry, Swine | Repellent Scent: Systemic absorption leads to secretion of repellent volatiles through the skin/pores, making the animal "invisible" or hostile to pests. | Sensory Camouflage: Masks the animal's CO2 and heat signature, confusing parasites before they can attach. |
| Candioli | Acarene Spray | Pyrethrins (Natural) + Piperonyl | Birds, Rabbits | Natural Neurotoxin: Uses natural Chrysanthemum extract to paralyze mites without the toxicity of synthetic organophosphates. | Safe for Exotics: The standard of care for delicate species (birds/rabbits) where synthetic chemicals are lethal. |
| Farnam | Equi-SpotÂ® | Permethrin (Botanical Analog) | Horses | Vector Control: Repels ticks (Lyme disease vectors) and flies that cause "Summer Eczema." | Vector Block: Not just a killer, but a repellentâ€”preventing the bite from happening in the first place. |
| Earth Animal | Natureâ€™s Protectionâ„¢ | Yeast, Garlic, B-Vitamins | Dogs, Cats | Metabolic Odor: Alters the dog's blood chemistry to produce a scent undetectable to humans but repulsive to fleas/ticks. | The "Daily Pill": A chemical-free oral alternative to the "Spot-On" drops, capitalizing on the "Clean Label" trend. |


## Sheet: Nutrigenomics

| Company | Product | Active Molecule | Genomic Mechanism | The Strategic Claim |
| --- | --- | --- | --- | --- |
| Bioiberica | NucleoforceÂ® | Free Nucleotides (RNA/DNA fragments) | Genomic Synthesis | The "Spare Parts": Provides pre-formed nucleotides, bypassing the body's energy-intensive DNA synthesis pathway. Essential for rapid cell division (Immunity/Growth). |
| Virbac | NovifitÂ® | SAMe (S-Adenosylmethionine) | Epigenetic Methylation | The "Master Switch": SAMe is the universal "Methyl Donor." It drives DNA methylation, which turns genes "on" or "off"â€”critical for cognitive repair and liver regeneration. |
| VetriScience | GlycoFlexÂ® | DMG (Dimethylglycine) | Epigenetic Regulation | The "Metabolic Optimizer": DMG is a methyl donor that supports the methylation cycle, reducing lactic acid build-up and modulating immune response genes. |
| Alltech | ActigenÂ® | Mannan-Rich Fraction (MRF) | Transcriptomics | The "Gene Tuner": Alltech is the only company using Gene Chips to prove their product physically down-regulates inflammation genes and up-regulates defense genes in the gut. |
| Zinpro | AvailaÂ® Zn | Zinc Amino Acid Complex | Transcription Factors | The "Barrier Builder": Proved via nutrigenomics that their specific Zinc up-regulates the genes coding for Claudin/Occludin (Tight Junction proteins), physically sealing the gut. |
| Embark | Breed + Health Kit | Genotyping Microarray (230k+ Markers) | Nutrigenetics (Genes -> Nutrition) | The "Risk Radar": Uses a research-grade array to detect genetic mutations (like HUU or Copper Toxicosis). Instead of changing genes, it identifies risks that require specific dietary interventions to prevent disease. |
| Orivet | GenoPet LifePlanâ„¢ | Integrated Health Algorithm | Personalized Wellness (Nutrigenetics) | The "Lifestyle Architect": The only test that automatically converts DNA data into a "LifePlan." It calculates specific caloric/nutritional needs based on the dog's unique breed mix, age, and genetic risk profile. |


## Sheet: Advanced Formulations 

| Company (Commercial) | Product | Nutraceutical Ingredients | Target Species | Technology Owner | The Strategic Claim | Proof of Relationship |
| --- | --- | --- | --- | --- | --- | --- |
| Balchem | ReaShureÂ® | Encapsulated Choline | Dairy | Balchem (Vertical) | Precision Encapsulation: Proprietary coating ensures nutrients survive the harsh rumen environment to reach the liver. | ðŸ”— Balchem ReaShure |
| NestlÃ© Purina | FortiFloraÂ® | E. faecium SF68 (Microencapsulated) | Dogs, Cats | NestlÃ© Research | Stability Assurance: Multi-layer microencapsulation guarantees the probiotic stays alive until it hits the bowl. | ðŸ”— Purina Institute |
| Zinpro | AvailaÂ® | Zinc/Manganese/Copper Amino Acid Complexes | Livestock | Zinpro (Vertical) | Active Transport: The only minerals that use specific amino-acid transporters to bypass digestion blocks (100% Bioavailable). | ðŸ”— Zinpro Science |
| Gelita | PetagileÂ® | Bioactive Collagen Peptides (BCPÂ®) | Dogs, Horses | Gelita (Vertical) | Molecular Tuning: Hydrolysis technology that cuts collagen into specific peptide lengths optimized for absorption into cartilage. | ðŸ”— Gelita Petagile |
| Swedencare | ProDen PlaqueOffÂ® | Ascophyllum nodosum (D1070â„¢ Kelp) | Dogs, Cats | Swedencare (Vertical) | Systemic Delivery: The only dental product that works via the bloodstream (secreted into saliva) rather than just scrubbing. | ðŸ”— Swedencare Tech |
| SmartPak | SmartPaksâ„¢ | Custom Supplements (Unit Dosing) | Horses, Dogs | SmartPak (Vertical) | Compliance Tech: Patented unit-dose packaging system that ensures 100% owner compliance and freshness stability. | ðŸ”— SmartPak Patents |
| Novus | MintrexÂ® | Chelated Trace Minerals (HMTBa) | Poultry, Swine | Novus Int. (Vertical) | Bidentate Chelation: Minerals are chemically clamped by two molecules, protecting them from breaking down in the gut. | ðŸ”— Novus Mintrex |


## Sheet: Mobility

| Technology Owner | Commercial Product | Range | Proof of Relationship | Direct Link (Where to look) |
| --- | --- | --- | --- | --- |
| Lonza (UC-IIÂ®) | Vetoquinol FlexadinÂ® Adv. | Vet | Trademark Footer: The official Vetoquinol product page explicitly states in the legal footer: "UC-IIÂ® and logo are trademarks of Lonza." | ðŸ”— Vetoquinol USA |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (Scroll to bottom of page) |
| Lintbells (ActivEaseÂ®) | YuMOVE Joint Care | Retail | Vertical Ownership: Lintbells' corporate site details their ownership of the mussel bays in NZ. | ðŸ”— Lintbells "Science" |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "From Source to Sea") |
| Aroma NZ (GlycOmegaâ„¢) | VetriScience GlycoFlexÂ® | Vet | Brochure Footer: The official sales brochure explicitly lists: "GlycOmegaâ„¢ is a trademark of Aroma New Zealand Ltd." | ðŸ”— GlycoFlex Brochure (PDF) |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See bottom of Page 2) |
| NestlÃ© (Patent) | Purina Bright MindÂ® | Food | Patent Assignment: The US Patent for "Enhancing Canine Cognitive Function" is assigned to Nestec SA (NestlÃ©). | ðŸ”— US Patent 8962050 |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Current Assignee") |


## Sheet: Cognitive

| Technology Owner | Commercial Product | Range | Proof of Relationship | Direct Link (Where to look) |
| --- | --- | --- | --- | --- |
| Ceva (AdaptilÂ®) | AdaptilÂ® Chew | Vet | Brand Owner: The official product site is hosted on Adaptil.com, which is copyrighted by Ceva Animal Health. | ðŸ”— Adaptil.com |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See Copyright Footer) |
| Ingredia (LactiumÂ®) | Vetoquinol ZylkÃ¨neÂ® | Vet | Ingredient Match: The Vetoquinol site lists the active as "alpha-casozepine" (the generic name for Lactium). | ðŸ”— Vetoquinol Zylkene |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Ingredients" tab) |
| Taiyo (SuntheanineÂ®) | Virbac AnxitaneÂ® | Vet | Tech Profile: Virbac's technical sheet explicitly displays the SuntheanineÂ® logo and attribution to Taiyo Kagaku. | ðŸ”— Virbac Tech Profile |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Suntheanine" Bullet Point) |
| ElleVet (Proprietary) | ElleVet Calm | DTC | Study Funding: The published Cornell study explicitly states: "Funding: This study was funded by ElleVet Sciences." | ðŸ”— Frontiers in Vet Science |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Funding" section) |


## Sheet: Immunity

| Technology Owner | Commercial Product | Range | Proof of Relationship | Direct Link (Where to look) |
| --- | --- | --- | --- | --- |
| NestlÃ© (SF68) | Purina FortiFloraÂ® | Vet | Proprietary Strain: The Purina Institute confirms E. faecium SF68 is their proprietary strain (NCIMB 10415). | ðŸ”— Purina Institute |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Proprietary Microencapsulation") |
| ADM (DE111Â®) | Zesty Paws Gut Health | Retail | Label Trademark: The ADM brochure highlights Zesty Paws as a case study for their DE111Â® strain. | ðŸ”— ADM Microbiome Brochure |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (Search for "DE111") |
| AnimalBiome | AnimalBiome Restore | DTC | Patent Inventor: The patent for "Therapeutic Administration of Microorganisms" lists founder Holly Ganz. | ðŸ”— US Patent App 2018 |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Inventor: Holly H. Ganz") |


## Sheet: Green 

| Technology Owner | Commercial Product | Range | Proof of Relationship | Direct Link (Where to look) |
| --- | --- | --- | --- | --- |
| DSM-Firmenich | Arla BovaerÂ® Pilot | Dairy | Official PR: Arla's corporate site hosts the press release: "Arla and DSM start large scale pilot." | ðŸ”— Arla Press Release |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (Headline) |
| Bond Pet Foods | Hill's Micro-Protein | Food | Official PR: Hill's official statement: "Hill's partners with Bond Pet Foods to develop alternative proteins." | ðŸ”— Pet Food Processing |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (Article Title) |
| Central Life (AltosidÂ®) | Purina Wind & RainÂ® | Farm | Product Name: The product is literally named "Wind & RainÂ® with AltosidÂ® IGR". | ðŸ”— Purina Mills Shop |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See Product Title) |


## Sheet: Specialized 

| Technology Owner | Commercial Product | Range | Proof of Relationship | Direct Link (Where to look) |
| --- | --- | --- | --- | --- |
| Innovet (RedonylÂ®) | Dechra RedonylÂ® | Vet | Annual Report: Dechra's 2017 Annual Report lists the acquisition of rights to Redonyl from Innovet. | ðŸ”— Dechra Annual Report |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  |  |
| Vetnique (GlandexÂ®) | Vetnique GlandexÂ® | Retail | Patent Assignee: The patent for "Anal gland health" is assigned directly to Vetnique Labs LLC. | ðŸ”— US Patent 9585925 |
|  |  |  |  |  |
|  |  |  |  |  |
|  |  |  |  | (See "Current Assignee") |


## Sheet: Microbiome 

| Company | Product / Platform | Target | Mechanism of Action (MoA) | Relation to Nutraceuticals (Regulatory Strategy) | The Strategic Claim |
| --- | --- | --- | --- | --- | --- |
| BiomEdit | Biome-Actives | Livestock | Synthetic Biology: Engineered microbial strains that produce specific enzymes/metabolites. | The "Trojan Horse": Functionally a precision drug, but legally classified as a Zootechnical Feed Additive to bypass pharma trials. | "Living Factories": Microbes that act as continuous manufacturing plants inside the gut. |
| Proteon | BAFASALÂ® | Poultry / Aqua | Bacteriophages: Lytic phages that selectively target and kill Salmonella. | The "Additive" Hack: Successfully lobbied to classify Phages as Feed Additives (not Vaccines), allowing them to be sold without a vet prescription. | "The Sniper": Kills superbugs without harming the beneficial microbiome (unlike antibiotics). |
| Folium Science | Guided Bioticsâ„¢ | Poultry | CRISPR-Cas: Technology that triggers self-destruction in pathogenic bacteria DNA. | The "Hygiene" Play: Positioned as a "Processing Aid" or Hygiene technology to avoid "GMO" labelling in sensitive markets. | "Genetic Scalpel": Removes pathogens by reading their DNA sequence; zero impact on good bacteria. |
| MicroHarvest | Single Cell Protein | Pet / Aqua | Biomass Fermentation: Bacteria that convert ag-waste into protein. | The "Super-Ingredient": Sold as a premium Feed Material (Protein source), evading the complex "Additive" approval process entirely. | "Speed & Scale": Produces protein 5000x faster than soy with a carbon-negative footprint. |
| Anizome | Discovery Platform | Multi | Therapeutic Discovery: Mapping the gut to find druggable targets. | The "Pharma Bridge": Does not sell a nutraceutical; sells Data to Big Pharma to help them create drugs derived from the microbiome. | "The Map Makers": Providing the "Google Maps" of the animal gut. |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |


## Sheet: New Business Models 

| Company | Model | Product | Strategic Similarity | Relation to Nutraceuticals (Regulatory Strategy) | The Differentiation |
| --- | --- | --- | --- | --- | --- |
| AnimalBiome | DTC (Direct to Consumer) | FMT & Testing: Poop pills & sequencing kits. | The "Patient Owner": Uses testing to sell supplements. | The "Wild West" Supplement: Operates as a Complementary Feed (Supplement). Relies on owner discretion rather than vet prescription or FDA approval. | "Ecosystem Transplant": The only scalable way to restore a lost microbiome after antibiotics. |
| Biome9 | DTC | AI Gut Test: At-home sequencing. | The "European Twin": Similar to AnimalBiome but UK-based. | The "Data Play": Sells the insight (Nutrigenomics) as the product; the nutraceutical is the upsell. | "Predictive AI": Claims to predict health issues before symptoms appear. |
| Gnubiotics | B2B (Ingredient) | Glycans: Structural mimics of milk oligosaccharides. | The "Intel Inside": Sells to Purina/Mars, not consumers. | The "Premium Nutrient": Classified as a Feed Material (like a vitamin), allowing instant adoption by big brands without safety dossiers. | "Motherâ€™s Milk Mimic": The first non-biological ingredient to replicate maternal immunity structures. |
| CanBiocin | B2B (Ingredient) | K9-17 Strain: Species-specific probiotics. | The "Strain Bank": Sells living tech to manufacturers. | The "Verified" Additive: Sells Approved Strains (EFSA/FDA listed) to validate claims on pet food bags. | "Native Logic": Bacteria isolated from dogs for dogs (higher colonization than human strains). |
| Bond Pet Foods | B2B (Ingredient) | Brewed Protein: Yeast-fermented meat proteins. | The "SynBio Chef": Creating meat without animals. | The "Food" Status: Navigating GRAS (Generally Recognized As Safe) to be sold as standard Pet Food, not a supplement. | "Nature Identical": Chemically identical to chicken protein, but made by yeast. |


## Sheet: Financial Performance  Margin 

| Segment | Market Size (2024) | EBITDA Margin | CAGR (2024â€“2030) | Risk Profile |  |
| --- | --- | --- | --- | --- | --- |
| Ingredient Suppliers (IP-based) | USD 1.5â€“2.0B | 25â€“30% | 8â€“10% | Medium (IP protection) |  |
| CDMOs & Premixers | USD 2.0â€“2.5B | 15â€“20% | 5â€“7% | Medium-High (customer concentration) |  |
| Pet Brands (Traditional) | USD 3.5â€“4.5B | 18â€“22% | 5.5â€“6.5% | High (low barriers to entry, CAC inflation) |  |
| Pet Brands (DTC) | USD 1.0â€“1.5B | 20â€“25% | 12â€“15% | High (CAC volatility, retention risk) |  |
| Livestock Integrators | USD 5.5â€“6.5B | 8â€“12% | 4.0â€“6.0% | Low (essential, sticky customers) |  |
|  |  |  |  |  |  |
| Sources: |  |  |  |  |  |
| DSM-Firmenich Q3 2025 Trading Update (Animal Nutrition 22.1% EBITDA) https://www.dsm-firmenich.com/content/dam/dsm-firmenich/investors/documents/results |  |  |  |  |  |
|  |  |  |  |  |  |
| Dechra Pharmaceuticals Annual Report 2023 (Pet brands 20-25%) https://www.dechra.com/Admin/Public/Download.aspx? |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |


## Sheet: Competition

| Layer / Archetype | Company | 2024 Revenue (approx.) | Primary Markets | Core Nutraceutical / Additive Focus | EBITDA Margin | Valuation Positioning | Strategic Positioning |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| PHARMA & ANIMAL HEALTH MAJORS |  |  |  |  |  |  |  |  |
| Pharma & Veterinary Pharma | Zoetis | USD 9.3B | Global (companion, livestock, aqua) | Vaccines, biologics, parasiticides; companion-animal supplements (joint, skin, gut). Divested feed additives. | 20â€“25%+ | High multiples (15â€“20x EBITDA) on pharma comps; quality/innovation premium | Market leader; focus on high-margin innovation; divesting commodity feed additives |  |
| Pharma & Veterinary Pharma | Merck Animal Health | USD 5.9B | Global (companion, livestock) | Livestock vaccines & therapeutics; BRAVECTO parasiticide (USD 1.1B); expanding aqua via Elanco acquisition | 18â€“22% | High multiples on quality assets | Pharma heritage; strong livestock and aqua platforms |  |
| Pharma & Veterinary Pharma | Boehringer Ingelheim Animal Health | EUR 4.7B (~USD 5.0B) | Global (companion, livestock) | NexGard parasiticide portfolio; SENVELGO (feline diabetes); poultry & ruminant solutions; vaccines | 18â€“20% | Premium multiples on innovation | Innovation-driven; strong R&D pipeline |  |
| Pharma & Veterinary Pharma | Phibro Animal Health | USD 1.4B (pro forma post-acquisition) | North America, international | Feed additives, specialty livestock products; acquired Zoetis MFA portfolio (USD 350M deal, 2024) | 15â€“18% | Mid-teens multiples | Consolidation play; feed-additive focus |  |
| Pharma & Veterinary Pharma | Elanco Animal Health | USD 4.4B | Global (companion, livestock) | Pet: parasiticides (Credelio Plus, Advantage), therapeutics; Farm: antibiotic alternatives (Experior), methane reduction | 0.205 | Mid-teens multiples | Recovery story; innovation (Zenrelia, Credelio Quattro); divestiture of aqua business |  |
| Pharma & Veterinary Pharma | Ceva SantÃ© Animale | EUR 1.77B (~USD 1.91B) | 47 countries (companion, livestock, aqua) | Nucleotide vaccines, gene therapy, immunology; preventive medicine focus | 15â€“18% | High valuation (EUR 9.2B recent round) | Pre-IPO; innovation-heavy; gene therapy differentiation |  |
| Pharma & Veterinary Pharma | Vetoquinol | EUR 539M (~USD 580M) | Global (companion, livestock) | Essential products: joint health (Dogmamil, ProfÂ®), oral care, digestive aids (60% of sales, growing 8%+ annually) | 16â€“18% | Mid-teens multiples | Strategic shift to high-margin preventive nutrition ("Essentials") |  |
| FEED & SPECIALTY NUTRITION MAJORS |  |  |  |  |  |  |  |  |
| Feed & Additives | DSM-Firmenich ANH | EUR 3.32B | Global (livestock, aqua) | Vitamins, minerals, probiotics, enzymes, methane-reduction additives (Bovaer), mycotoxin solutions | 0.103 | Mid-single to mid-teens multiples | Science-driven; sustainability focus (ESG); margin expansion via premium additives |  |
| Feed & Additives | Novonesis (Novozymes + Chr. Hansen) | EUR 2.10B (H1 2025) | Global (livestock, aqua) | Fermentation-based probiotics, enzymes, yeast derivatives, organic acids; Planetary Health segment (37.4% EBITDA margin) | >35% (specialty) | High multiples (15â€“20x) on biotech comps | Microbial biotech platform; exceptional margins on fermentation IP |  |
| Feed & Additives | Cargill Animal Nutrition | ~USD 10â€“12B (part of USD 165B+ company) | Global (livestock, aqua, pet) | Premixes (Provimi), yeast products (Diamond V), phytogenics (Delacon), aquafeed (EWOS); methane solutions (SilvAirâ„¢) | 10â€“12% | Integrated conglomerate valuation | Scale & vertical integration; precision nutrition focus |  |
| Feed & Additives | ADM Animal Nutrition | ~USD 2â€“3B (segment) | Global (livestock, aqua) | Amino acids, protein meals, enzymes, probiotics, mycotoxin solutions; organic acids | 8â€“10% | Mid-single digit multiples | Recovery mode (2024 improved); leveraging fermentation capabilities |  |
| Feed & Additives | Alltech (merging with ADM) | ~USD 2â€“2.5B (private) | Global (livestock, aqua) | Yeast products, fermentation science, organic acids, probiotics | 10â€“14% | Merger consideration TBD | Fermentation biotech specialist; merger expected to create scale |  |
| Feed & Additives | Nutreco (Trouw Nutrition) | EUR 8B+ (parent company) | Global (livestock, aqua) | Premixes, specialty ingredients, methane solutions, gut-health diagnostics | 8â€“10% | Mid-single digit multiples | Regional consolidation; sustainability messaging |  |
| Feed & Additives | ForFarmers | EUR 2.75B | Europe (livestock) | Compound feeds, premixes, additive blends; low-cost producer model | 0.037 | Single-digit multiples | Commodity-exposed; consolidating regionally |  |
| PET FOOD & SUPPLEMENT BRANDS |  |  |  |  |  |  |  |  |
| Pet Brands | NestlÃ© Purina PetCare | ~USD 22.4B (U.S. estimate) | Global (primarily North America, Europe, Asia) | 900+ products across premium (PRO PLAN) and mass-market brands; joint, digestive, senior, immune formulations | 20â€“24% | Premium multiples (15â€“20x EBITDA) on CPG comps | Market leader; scale & innovation; pet humanization positioning |  |
| Pet Brands | Mars Petcare | ~USD 22B (estimate) | Global (50+ brands) | PEDIGREE, Whiskas, Royal Canin, Iams, Cesar, Greenies; premium nutrition & therapeutic positioning | 20â€“23% | Premium multiples on brand equity | Market leader; brand strength; vertical integration (vet services) |  |
| Pet Brands | Hill's Pet Nutrition | USD 4.4B | Global (veterinary channel primary) | Therapeutic & prescription diets (joint, kidney, digestive); 300+ SKUs; veterinary-endorsed | 22â€“25% | High multiples (15â€“18x EBITDA) on vet-channel positioning | Veterinary professional differentiation; clinical evidence strength |  |
| Pet Brands | General Mills Pet (Blue Buffalo) | USD 2.3B | North America (declining 4% FY2024) | Premium natural pet food; joint health, immune support, digestive wellness; strong DTC/subscription | 18â€“20% | Mid-teens multiples; declining trajectory | Premium positioning; e-commerce/DTC focus; facing consolidation pressure |  |
| Pet Brands | Swedencare AB | ~EUR 70â€“75M (~USD 75â€“80M) | Europe, North America, select global | High-margin joint health (Arthropharm), oral health (Trixie), digestive aids; veterinary-channel & DTC | >20% | High multiples (15â€“20x EBITDA) on growth | High-growth niche player; Scandinavian premium positioning |  |
| Pet Brands | Freshpet | ~USD 500M+ | North America | Fresh/refrigerated pet food; premium natural positioning; positive net income 2024 | 15â€“18% | Mid-teens multiples on growth | Positive inflection; fresh/natural category leadership |  |
| Pet Brands | Nutramax Laboratories | Private (~USD 500M+ estimate) | North America (veterinary channel) | Dasuquin (joint, peer-reviewed), Cosaquin; clinical differentiation driving premium pricing | 22â€“26% | Very high multiples (18â€“25x EBITDA) on clinical data + brand | Clinical evidence as competitive moat |  |
| Pet Brands | Nulo Pet Food | USD 261.8M | North America (premium retail & online) | Premium natural pet food; grain-free, high-protein positioning; 2.1% growth | 18â€“22% | Mid-teens multiples | Premium segment; steady growth |  |
| Pet Brands | Wellness Pet | Private (USD 300â€“400M estimate) | North America | Premium natural pet food & supplements; owned by Clearlake Capital; strong DTC | 20â€“24% | High multiples on brand value | Premium natural positioning; PE-backed |  |
| RETAIL & DISTRIBUTION |  |  |  |  |  |  |  |  |
| Distribution | Chewy Inc. | ~USD 9B | North America (online dominant) | E-commerce platform; private-label pet food & supplements; veterinary partnerships; subscription model | 12â€“15% | High-growth multiples (premium) | Data aggregation; veterinary integration; margin expansion via private-label |  |
| Distribution | Veterinary Practice Groups | Fragmented (~USD 100B+ aggregate) | Local/regional | Formulary curation; private-label supplement development; direct client relationships | 15â€“25% (varies) | Varies by size and consolidation | Trusted advisor positioning; increasing M&A consolidation |  |
| Distribution | Pet Specialty Retail | Consolidated (~USD 15â€“20B aggregate) | North America, Europe | PetSmart, Petco (Amoeba), Pets at Home, etc.; shelf curation; private-label development | 8â€“12% | Mid-single digit multiples | Margin pressure from e-commerce; increasing private-label |  |
|  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |


